# Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease

> **NCT01678599** · PHASE4 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 220 (actual)

## Conditions studied

- Chagas Disease

## Interventions

- **DRUG:** Benznidazole

## Key facts

- **NCT ID:** NCT01678599
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2018-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01678599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01678599, "Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01678599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*